Grown Rogue International (GRUSF) Total Debt Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Total Debt Growth (3y) (2012 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -7.03% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.29% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -58.89% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -12.80% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 72.82% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -4.66% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2023 | -22.95% |
| Apr 30, 2021 | 71.03% |
| Oct 31, 2020 | 52.18% |
| May 31, 2018 | -42.50% |
| Feb 28, 2018 | 26.24% |
| Nov 30, 2017 | 26.12% |
| May 31, 2017 | 68.52% |
| Feb 28, 2017 | -23.58% |
| Nov 30, 2016 | 117.68% |
| Nov 30, 2015 | -144.07% |
| Aug 31, 2015 | 52.48% |
| May 31, 2015 | -20.90% |
| Feb 28, 2015 | -55.29% |
| Nov 30, 2014 | -49.17% |
| Aug 31, 2014 | -0.81% |
| May 31, 2014 | -80.60% |
| Feb 28, 2014 | -58.92% |
| Nov 30, 2013 | -58.54% |
| Aug 31, 2013 | 7.84% |
| May 31, 2013 | -18.76% |